|
1
|
Doroshow JH and Parchment RE: Oncologic
phase 0 trials incorporating clinical pharmacodynamics: from
concept to patient. Clin Cancer Res. 14:3658–3663. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kuhlmann J and Wensing G: The applications
of biomarkers in early clinical drug development to improve
decision-making processes. Curr Clin Pharmacol. 1:185–191. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kan Z, Jaiswal BS, Stinson J, Janakiraman
V, Bhatt D, Stern HM, Yue P, Haverty PM, Bourgon R, Zheng J,
Moorhead M, Chaudhuri S, Tomsho LP, Peters BA, Pujara K, Cordes S,
Davis DP, Carlton VE, Yuan W, Li L, Wang W, Eigenbrot C, Kaminker
JS, Eberhard DA, Waring P, Schuster SC, Modrusan Z, Zhang Z, Stokoe
D, De Sauvage FJ, Faham M and Seshagiri S: Diverse somatic mutation
patterns and pathway alterations in human cancers. Nature.
466:869–873. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maheswaran S, Sequist LV, Nagrath S, Ulkus
L, Brannigan B, Collura CV, Inserra E, Diederichs S, Lafrate AJ,
Bell DW, Digumarthy S, Muzikansky A, Irimia D, Settleman J,
Tompkins RG, Lynch TJ, Toner M and Haber DA: Detection of mutations
in EGFR in circulating lung-cancer cells. N Engl J Med.
359:366–377. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dotan E, Cohen SJ, Alpaugh KR and Meropol
NJ: Circulating tumor cells: evolving evidence and future
challenges. Oncologist. 14:1070–1082. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Krebs MG, Hou JM, Ward TH, Blackhall FH
and Dive C: Circulating tumour cells: their utility in cancer
management and predicting outcomes. Ther Adv Med Oncol. 2:351–365.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hou JM, Krebs M, Ward T, Sloane R, Priest
L, Hughes A, Clack G, Ranson M, Blackhall F and Dive C: Circulating
tumor cells as a window on metastasis biology in lung cancer. Am J
Pathol. 178:989–996. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Simpson SJ, Vachula M, Kennedy MJ, Kaizer
H, Coon JS, Ghalie R, Williams S and van Epps D: Detection of tumor
cells in the bone marrow, peripheral blood, and apheresis products
of breast cancer patients using flow cytometry. Exp Hematol.
23:1062–1068. 1995.PubMed/NCBI
|
|
9
|
Ring AE, Zabaglo L, Ormerod MG, Smith IE
and Dowsett M: Detection of circulating epithelial cells in the
blood of patients with breast cancer: comparison of three
techniques. Br J Cancer. 92:906–912. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nagrath S, Sequist LV, Maheswaran S, Bell
DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky
A, Ryan P, Balis UJ, Tompkins RG, Haber DA and Toner M: Isolation
of rare circulating tumour cells in cancer patients by microchip
technology. Nature. 450:1235–1239. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bossolasco P, Ricci C, Farina G, Soligo D,
Pedretti D, Scanni A and Deliliers GL: Detection of micrometastatic
cells in breast cancer by RT-pCR for the mammaglobin gene. Cancer
Detect Prev. 26:60–63. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Iakovlev VV, Goswami RS, Vecchiarelli J,
Arneson NC and Done SJ: Quantitative detection of circulating
epithelial cells by Q-RT-PCR. Breast Cancer Res Treat. 107:145–154.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xenidis N, Perraki M, Kafousi M,
Apostolaki S, Bolonaki I, Stathopoulou A, Kalbakis K, Androulakis
N, Kouroussis C, Pallis T, Christophylakis C, Argyraki K, Lianidou
ES, Stathopoulos S, Georgoulias V and Mavroudis D: Predictive and
prognostic value of peripheral blood cytokeratin-19 mRNA-positive
cells detected by real-time polymerase chain reaction in
node-negative breast cancer patients. J Clin Oncol. 24:3756–3762.
2006. View Article : Google Scholar
|
|
14
|
Cristofanilli M, Budd GT, Ellis MJ,
Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ,
Terstappen LW and Hayes DF: Circulating tumor cells, disease
progression, and survival in metastatic breast cancer. N Engl J
Med. 351:781–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cohen SJ, Punt CJ, Iannotti N, Saidman BH,
Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC,
Doyle GV, Tissing H, Terstappen LW and Meropol NJ: Relationship of
circulating tumor cells to tumor response, progression-free
survival, and overall survival in patients with metastatic
colorectal cancer. J Clin Oncol. 26:3213–3221. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Riethdorf S, Fritsche H, Müller V, Rau T,
Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Jänicke F, Jackson
S, Gornet T, Cristofanilli M and Pantel K: Detection of circulating
tumor cells in peripheral blood of patients with metastatic breast
cancer: a validation study of the CellSearch system. Clin Cancer
Res. 13:920–928. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Allard WJ, Matera J, Miller MC, Repollet
M, Connelly MC, Rao C, Tibbe AG, Uhr JW and Terstappen LW: Tumor
cells circulate in the peripheral blood of all major carcinomas but
not in healthy subjects or patients with nonmalignant diseases.
Clin Cancer Res. 10:6897–6904. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tibbe AG, Miller MC and Terstappen LW:
Statistical considerations for enumeration of circulating tumor
cells. Cytometry A. 71:154–162. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nedosekin DA, Sarimollaoglu M, Ye JH,
Galanzha EI and Zharov VP: In vivo ultra-fast photoacoustic
flow cytometry of circulating human melanoma cells using
near-infrared high-pulse rate lasers. Cytometry A. 79:825–833.
2011. View Article : Google Scholar
|
|
20
|
Barber CJ: Central venous catheter
placement for intravenous digital subtraction angiography: an
assessment of technical problems and success rate. Br J Radiol.
62:599–602. 1989. View Article : Google Scholar
|
|
21
|
Stanton AW, Holroyd B, Northfield JW,
Levick JR and Mortimer PS: Forearm blood flow measured by venous
occlusion plethysmography in healthy subjects and in women with
postmastectomy oedema. Vascular Med. 3:3–8. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Florek E, Bręborowicz GH, Lücke K,
Madejczyk M, Chuchracki M, Dworacki G, Zabel M and Giersig M: The
acute systemic toxicity study for normal catheter and cell-select
catheter (CSC). Arch Perinatal Med. 14:20–31. 2008.
|
|
23
|
Xu FJ, Li YL, Kang ET and Neoh KG:
Heparin-coupled poly(poly(ethylene-glycol)
monomethacrylate)-Si(111)) hybrids and their blood compatible
surfaces. Biomacromolecules. 6:1759–1768. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fortune JB and Feustel P: Effect of
patient position on size and location of the subclavian vein for
percutaneous puncture. Arch Surg. 138:996–1000. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Larson CJ, Moreno JG, Pienta KJ, Gross S,
Repollet M, O’Hara SM, Russell T and Terstappen LW: Apoptosis of
circulating tumor cells in prostate cancer patients. Cytometry A.
62:46–53. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Coumans FA, Doggen CJ, Attard G, De Bono
JS and Terstappen LW: All circulating
EpCAM+CK+CD45− objects predict
overall survival in castration-resistant prostate cancer. Ann
Oncol. 21:1851–1857. 2010.
|
|
27
|
Cristofanilli M, Hayes DF, Budd GT, Ellis
MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC,
Fritsche HA, Hortobagyi GN and Terstappen LW: Circulating tumor
cells: a novel prognostic factor for newly diagnosed metastatic
breast cancer. J Clin Oncol. 23:1420–1430. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhe X, Cher ML and Bonfil RD: Circulating
tumor cells: finding the needle in the haystack. Am J Cancer Res.
1:740–751. 2011.PubMed/NCBI
|
|
29
|
Steeg PS and Theodorescu D: Metastasis: a
therapeutic target for cancer. Nat Clin Pract Oncol. 5:206–219.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Graves H and Czerniecki BJ: Circulating
tumor cells in breast cancer patients: an evolving role in patient
prognosis and disease progression. Patholog Res Int.
2011:6210902011.PubMed/NCBI
|
|
31
|
Molloy TJ, Devriese LA, Helgason HH, Bosma
AJ, Hauptmann M, Voest EE, Schellens JH and van’t Veer LJ: A
multimarker QPCR-based platform for the detection of circulating
tumour cells in patients with early-stage breast cancer. Br J
Cancer. 104:1913–1919. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Q, Qi H, Zhou HX, Deng CY, Zhu H, Li
JF, Wang XL and Li FR: Detection of micrometastases in peripheral
blood of non-small cell lung cancer with a refined immunomagnetic
nanoparticle enrichment assay. Int J Nanomed. 6:2175–2181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
O’Flaherty JD, Gray S, Richard D, Fennell
D, O’Leary JJ, Blackhall FH and O’Byrne KJ: Circulating tumour
cells, their role in metastasis, and their clinical utility in lung
cancer. Lung Cancer. 76:19–25. 2012.PubMed/NCBI
|
|
34
|
Sun YF, Yang XR, Zhou J, Qiu SJ, Fan J and
Xu Y: Circulating tumor cells: advances in detection methods,
biological issues, and clinical relevance. J Cancer Res Clin Oncol.
137:1151–1173. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Alunni-Fabbroni M and Sandri MT:
Circulating tumour cells in clinical practice: methods of detection
and possible characterization. Methods. 50:289–297. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ross JS and Slodkowska EA: Circulating and
disseminated tumor cells in the management of breast cancer. Am J
Clin Pathol. 132:237–245. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Allan AL and Keeney M: Circulating tumor
cell analysis: technical and statistical considerations for
application to the clinic. J Oncol. 2010:4262182010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Van de Stolpe A, Pantel K, Sleijfer S,
Terstappen LW and Den Toonder JM: Circulating tumor cell isolation
and diagnostics: toward routine clinical use. Cancer Res.
71:5955–5960. 2011.PubMed/NCBI
|
|
39
|
Sleijfer S, Gratama JW, Sieuwerts AM,
Kraan J, Martens JW and Foekens JA: Circulating tumour cell
detection on its way to routine diagnostic implementation? Eur J
Cancer. 43:2645–2650. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Paterlini-Brechot P and Benali NL:
Circulating tumor cells (CTC) detection: clinical impact and future
directions. Cancer Lett. 253:180–204. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Swaby RF and Cristofanilli M: Circulating
tumor cells in breast cancer: a tool whose time has come of age.
BMC Med. 9:432011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Blümke K, Bilkenroth U, Schmidt U,
Melchior A, Füssel S, Bartel F, Heynemann H, Fornara P, Taubert H,
Wirth MP and Meye A: Detection of circulating tumor cells from
renal carcinoma patients: experiences of a two-center study. Oncol
Rep. 14:895–899. 2005.PubMed/NCBI
|
|
43
|
Nichols AC, Lowes LE, Szeto CC, Basmaji J,
Dhaliwal S, Chapeskie C, Todorovic B, Read N, Venkatesan V, Hammond
A, Palma DA, Winquist E, Ernst S, Fung K, Franklin JH, Yoo J,
Koropatnick J, Mymryk JS, Barrett JW and Allan AL: Detection of
circulating tumor cells in advanced head and neck cancer using the
Cellsearch system. Head Neck. View Article : Google Scholar : [Epub ahead of
print]. 2011.PubMed/NCBI
|
|
44
|
Lecharpentier A, Vielh P, Perez-Moreno P,
Planchard D, Soria JC and Farace F: Detection of circulating tumour
cells with a hybrid (epithelial/mesenchymal) phenotype in patients
with metastatic non-small cell lung cancer. Br J Cancer.
105:1338–1341. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cohen SJ, Punt CJ, Iannotti N, Saidman BH,
Sabbath KD, Gabrail NY, Picus J, Morse MA, Mitchell E, Miller MC,
Doyle GV, Tissing H, Terstappen LW and Meropol NJ: Prognostic
significance of circulating tumor cells in patients with metastatic
colorectal cancer. Ann Oncol. 20:1223–1229. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
De Bono JS, Scher HI, Montgomery RB,
Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ
and Raghavan D: Circulating tumor cells predict survival benefit
from treatment in metastatic castration-resistant prostate cancer.
Clin Cancer Res. 14:6302–6309. 2008.PubMed/NCBI
|
|
47
|
Poveda A, Kaye SB, McCormack R, Wang S,
Parekh T, Ricci D, Lebedinsky CA, Tercero JC, Zintl P and Monk BJ:
Circulating tumor cells predict progression free survival and
overall survival in patients with relapsed/recurrent advanced
ovarian cancer. Gynecol Oncol. 122:567–572. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bear HD: Measuring circulating tumor cells
as a surrogate end point for adjuvant therapy of breast cancer:
what do they mean and what should we do about them? J Clin Oncol.
26:1195–1197. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Pachmann K, Camara O, Kavallaris A,
Krauspe S, Malarski N, Gajda M, Kroll T, Jörke C, Hammer U,
Altendorf-Hofmann A, Rabenstein C, Pachmann U, Runnebaum I and
Höffken K: Monitoring the response of circulating epithelial tumor
cells to adjuvant chemotherapy in breast cancer allows detection of
patients at risk of early relapse. J Clin Oncol. 26:1208–1215.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Bidard FC, Mathiot C, Delaloge S, Brain E,
Giachetti S, De Cremoux P, Marty M and Pierga JY: Single
circulating tumor cell detection and overall survival in
nonmetastatic breast cancer. Ann Oncol. 21:729–733. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hofman VJ, Ilie MI, Bonnetaud C, Selva E,
Long E, Molina T, Vignaud JM, Fléjou JF, Lantuejoul S, Piaton E,
Butori C, Mourad N, Poudenx M, Bahadoran P, Sibon S, Guevara N,
Santini J, Vénissac N, Mouroux J, Vielh P and Hofman PM:
Cytopathologic detection of circulating tumor cells using the
isolation by size of epithelial tumor cell method: promises and
pitfalls. Am J Clin Pathol. 135:146–156. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Rolle A, Günzel R, Pachmann U, Willen B,
Höffken K and Pachmann K: Increase in number of circulating
disseminated epithelial cells after surgery for non-small cell lung
cancer monitored by MAINTRAC(R) is a predictor for relapse: a
preliminary report. World J Surg Oncol. 3:182005. View Article : Google Scholar
|
|
53
|
Fehm T, Solomayer EF, Meng S, Tucker T,
Lane N, Wang J and Gebauer G: Methods for isolating circulating
epithelial cells and criteria for their classification as carcinoma
cells. Cytotherapy. 7:171–185. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Gascoyne PR, Noshari J, Anderson TJ and
Becker FF: Isolation of rare cells from cell mixtures by
dielectrophoresis. Electrophoresis. 30:1388–1398. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Mostert B, Kraan J, Sieuwerts AM, van der
Spoel P, Bolt-De Vries J, Prager-van der Smissen WJ, Smid M,
Timmermans AM, Martens JW, Gratama JW, Foekens JA and Sleijfer S:
CD49f-based selection of circulating tumor cells (CTC) improves
detection across breast cancer subtypes. Cancer Lett. 319:49–55.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Farace F, Massard C, Vimond N, Drusch F,
Jacques N, Billiot F, Laplanche A, Chauchereau A, Lacroix L,
Planchard D, Le Moulec S, André F, Fizazi K, Soria JC and Vielh P:
A direct comparison of CellSearch and ISET for circulating
tumour-cell detection in patients with metastatic carcinomas. Br J
Cancer. 105:847–853. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Flores LM, Kindelberger DW, Ligon AH,
Capelletti M, Fiorentino M, Loda M, Cibas ES, Jänne PA and Krop IE:
Improving the yield of circulating tumour cells facilitates
molecular characterisation and recognition of discordant HER2
amplification in breast cancer. Br J Cancer. 102:1495–1502. 2010.
View Article : Google Scholar : PubMed/NCBI
|
